Mid-year update
Quarterly performance reports released

Mid-year update

In October 2021, Health Canada published Mid-year update: Health products approved in 2021, which provides an update on the drugs, medical devices, over-the-counter (non-prescription) drugs and natural health products approved by Health Canada in the period from January 2021 to June 2021, together with an overview of steps taken to improve access to these categories of products. This update includes sections on:

  • Health Canada's covid-19 regulatory response;
  • drugs for human use (eg, the approval of 43 new drugs (including three new biosimilar drugs) and 82 new generic drugs);
  • over-the-counter drugs and natural health products;
  • drugs for veterinary use;
  • medical devices;
  • an update on Health Canada's public release of clinical information, now in its third year; and
  • information on adverse reaction and incident-reporting.

Quarterly performance reports released

The Therapeutic Products Directorate, Biologic and Radiopharmaceutical Drugs Directorate, Medical Devices Directorate and the Natural and Non-Prescription Health Products Directorate have released their quarterly reports, which cover April-June 2021. The reports include information on the number of submissions or applications made and the number of approvals in the first quarter of 2020-2021.

For further information on this topic please contact Katie Lee at Smart & Biggar by telephone (+1 416 593 5514) or email ([email protected]). The Smart & Biggar website can be accessed at www.smartbiggar.ca.